ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 161 filers reported holding ANIKA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,592
-99.8%
139,114
+365.2%
0.00%
+200.0%
Q4 2021$1,072,000
-15.2%
29,906
+0.7%
0.00%
-50.0%
Q3 2021$1,264,000
-41.7%
29,696
-40.7%
0.00%
-33.3%
Q2 2021$2,167,000
+21.8%
50,061
+6.2%
0.00%0.0%
Q2 2020$1,779,000
-21.1%
47,155
-39.5%
0.00%
-50.0%
Q1 2020$2,255,000
-79.0%
77,990
-62.3%
0.01%
-76.0%
Q4 2019$10,736,000
+138.3%
207,060
+152.2%
0.02%
+127.3%
Q3 2019$4,506,000
+40.7%
82,087
+4.1%
0.01%
+57.1%
Q2 2019$3,203,000
+77.8%
78,863
+32.4%
0.01%
+75.0%
Q1 2019$1,801,00059,5630.00%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Euclidean Technologies Management, LLC 44,875$2,031,0002.14%
Parian Global Management LP 102,705$4,648,0001.16%
CAPITAL MANAGEMENT CORP /VA 93,035$4,211,0001.15%
Avidity Partners Management LP 731,000$33,085,0001.07%
Sio Capital Management, LLC 65,382$2,959,0000.61%
DIKER MANAGEMENT LLC 21,835$988,0000.50%
Archon Capital Management LLC 48,925$2,214,0000.38%
Caption Management, LLC 362,800$16,420,0000.37%
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 1,546,260$69,984,0000.20%
Boston Trust Walden Corp 378,167$17,116,0000.18%
View complete list of ANIKA THERAPEUTICS INC shareholders